Items Tagged ‘cyclin-dependent kinase 4 and 6’

November 14, 2017

Kisqali® Improves Outcomes for Premenopausal Women with HR+/HER2- Advanced Breast Cancer


Premenopausal breast cancer is a biologically distinct and more aggressive disease than postmenopausal breast cancer and is the leading cause of cancer death in women 20-59 years old.1,2 ,3 Historically there younger women were treated the same as their older counterparts, researchers however have more recently begun to focus on improving the treatment outcomes for […]

View full entry

Tags: advanced breast cancer, Breast Cancer, CDK4/6, cyclin-dependent kinase 4 and 6, kisqali, MONALEESA-7, News, Precision Cancer Medicine, ribociclib